PI-LAB-2025-060

Teriparatide, Independent Lab Report

Teriparatide 0.62mg · NextGen Peptides

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 96.9% met the stated ≥98% claim. Content measured 100.7% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
96.9%

Label claimed ≥98%

Content accuracy
100%

0.62mg measured against 0.62mg claimed

Test recency
Older result

Published 16 months ago

Specimen PI-LAB-2025-060 Tested by Axiom Mass Spec Services 17 samples tested from this company Purity & Testing score 91/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 96.9% Within analytical tolerance
Identity (MS) Teriparatide Confirmed Matches label
Content 0.62 mg 0.62 mg Within 5% of label

Methodology & chain of custody

LC-MS/MS identity confirmation with quantitative amino acid analysis.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Axiom Mass Spec Services. See our full testing methodology.

Lot / batch
B5998-25
Purchased
Analysed
Published
Laboratory
Axiom Mass Spec Services
Test type
Purity, identity & content

Original laboratory report: PI-LAB-2025-060-report.pdf (document delivery arrives with the production storage backend)

More Tests, NextGen Peptides

PT-141
Purity 98.5% Verified
Retatrutide
Purity 99.7% Verified
Tirzepatide/Cagrilintide Blend
Purity 97.6% Verified